541 related articles for article (PubMed ID: 32312017)
21. Transaxillary robotic modified radical neck dissection: a 5-year assessment of operative and oncologic outcomes.
Kim MJ; Lee J; Lee SG; Choi JB; Kim TH; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jo YS; Chung WY
Surg Endosc; 2017 Apr; 31(4):1599-1606. PubMed ID: 27572060
[TBL] [Abstract][Full Text] [Related]
22. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
[TBL] [Abstract][Full Text] [Related]
23. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
24. Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.
Yu ST; Ge JN; Sun BH; Wei ZG; Xiao ZZ; Zhang ZC; Chen WS; Li TT; Lei ST
Oral Oncol; 2021 Dec; 123():105567. PubMed ID: 34710736
[TBL] [Abstract][Full Text] [Related]
25. [ANAPLASTIC TRANSFORMATION OF METASTATIC PAPILLARY THYROID CARCINOMA IN A CERVICAL LYMPH NODE - A TIMELINE].
Horev Y; Vaknine H; Cinamon U
Harefuah; 2020 Nov; 159(11):809-814. PubMed ID: 33210851
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study on papillary thyroid carcinoma presenting with lymph node metastasi].
Mizumachi T; Oridate N; Homma A; Nagahashi T; Furuta Y; Fukuda S
Nihon Jibiinkoka Gakkai Kaiho; 2004 Aug; 107(8):750-5. PubMed ID: 15457986
[TBL] [Abstract][Full Text] [Related]
27. Total thyroidectomy with therapeutic level II-IV neck dissection for papillary thyroid carcinoma: level VI recurrence patterns.
Carmel-Neiderman NN; Duek I; Amsterdam D; Wengier A; Kuzmenko B; Ringel B; Warshavsky A; Shapira U; Horowitz G; Izkhakov E; Fliss DM
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3449-3455. PubMed ID: 32488373
[TBL] [Abstract][Full Text] [Related]
28. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
[TBL] [Abstract][Full Text] [Related]
29. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
31. Synchronous occurrence of papillary thyroid carcinoma and early esophageal squamous cell carcinoma in a 45-year-old female: a case report and review of the literature.
Altam A; Alsaaidi A; Aljbri W; Ahmed F; Alyhari Q; Badheeb M
Pan Afr Med J; 2022; 42():248. PubMed ID: 36303817
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcomes and prognostic factors for patients with papillary thyroid carcinoma with other organ invasions after adjuvant radioactive iodine.
Kawamoto T; Shikama N; Fukumori T; Hoshi M; Yamada T
Endocrine; 2023 Apr; 80(1):79-85. PubMed ID: 36367673
[TBL] [Abstract][Full Text] [Related]
33. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
[TBL] [Abstract][Full Text] [Related]
34. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
35. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
36. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
[TBL] [Abstract][Full Text] [Related]
37. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
[TBL] [Abstract][Full Text] [Related]
38. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
39. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
Wu Z; Han L; Li W; Wang W; Chen L; Yao Y; Wang Y
Cancer Med; 2021 Mar; 10(5):1614-1622. PubMed ID: 33512778
[TBL] [Abstract][Full Text] [Related]
40. Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
Bellantone R; Raffaelli M; De Crea C; Sessa L; Traini E; Princi P; Lombardi CP
World J Surg; 2018 Feb; 42(2):402-408. PubMed ID: 29238849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
